Cohance Lifesciences plans $18 million investment in NJ Bio
Cohance Lifesciences Ltd said it will invest USD 18 million in NJ Bio and Aruka Bio, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.